The significant tumor growth inhibition in combination-treated mice was mediated by reduced total and active levels of HER2, EGFR, and c-Met, compared to individual OC or LP treatments (Figure 6E), suggesting effective tumor cell sensitization. This evidence concerns the gene ERBB2 and neoplasm.